According to the U.S. Department of Health and Human Services, 11.5 million people misused prescription opioids, and 116 people passed away every day due to opioid-related drug overdoses in 2016. Fast forward a year later, and the HHS declared the opioid crisis a public health emergency and president Trump signs the “Special Registration for Telemedicine Act of 2018”.
From a physician’s standpoint, there is a way to stop the opioid crisis and aid America back to health based on several of the priorities the HHS laid out. Telemedicine is one way to increase patient’s access to care and reduce very common barriers to addiction treatment – travel and cost.
During this webinar, learn from the experiences of Evergreen Treatment Services, a nonprofit organization delivering evidence-based substance use disorder and social services. Find out how Evergreen Treatment Services is able to treat 60 more addiction patients a week, that without telehealth they would not be able to provide consistent treatment for.
Since 2015, they have been leveraging telemedicine to administer ongoing Suboxone prescriptions and mentor their patient’s along their treatment path. We will also discuss the landscape of the regulatory policies around the virtual prescribing of scheduled medication.
How Telemedicine Fits and Regulatory Policies
- Opportunities to increase patient volume but decrease cost of care
- Department of Health and Human Services top 5 priorities
- Special Registration Telemedicine Act of 2018
Use of Telemedicine for the Flex Care Program
- Flex Care program overview and structure
- How telemedicine is used for addiction treatment (benefits)
- Future directions
Ron Emerson, RN BSN
Global Director of Strategic Development
Dr. James Darnton
Flex Care Medical Provider
Flex Care Program Manager